- Home
- APGE
as 07-26-2024 4:00pm EST
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Its two programs are APG777 and APG808, which initially develop for treating AD and COPD, respectively.
| Founded: | 2022 | Country: | United States |
| Employees: | N/A | City: | WALTHAM |
| Market Cap: | 2.4B | IPO Year: | 2023 |
| Target Price: | $65.80 | AVG Volume (30 days): | 523.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -5.25 | EPS Growth: | N/A |
| 52 Week Low/High: | $14.19 - $72.29 | Next Earning Date: | 08-26-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of Apogee Therapeutics Inc. (APGE)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| HENDERSON MICHAEL THOMAS | APGE | Chief Executive Officer | Jul 5 '24 | Sell | $37.26 | 15,000 | $558,900.00 | 1,474,487 | SEC Form 4 |
Latest Apogee Therapeutics Inc. News
APGE Breaking Stock News: Dive into APGE Ticker-Specific Updates for Smart Investing
GlobeNewswire
9 days ago
NewAmsterdam Pharma Announces Appointments of Mark C. McKenna and Wouter Joustra to its Board of Directors
GuruFocus.com
21 days ago
Insider Sale: CEO Michael Henderson Sells 15,000 Shares of Apogee Therapeutics Inc (APGE)
GuruFocus.com
21 days ago
Insider Sale: Carl Dambkowski Sells Shares of Apogee Therapeutics Inc (APGE)
Investor's Business Daily
2 months ago
Dow Jones Falls On Jobs Report; GameStop Plunges Ahead Of 'Roaring Kitty' Live Event
Yahoo Finance Video
2 months ago
Can DocuSign's AI offering accelerate growth?
GlobeNewswire
2 months ago
Lab-on-a-Chip and Microfluidics World Congress 2024: 3-Day Conference (Laguna Hills, United States - November 18-20, 2024) Covering Technologies, Companies and Commercialization
Reuters
2 months ago
Analysis-Mexico investors worry lopsided vote could threaten rule of law
Investor's Business Daily
2 months ago
AI Boom Giving Taiwan Semiconductor Sales A Boost
Compare APGE vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "APGE Apogee Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.